A Supportive Care Programme for People With Heart Failure
SupportHeart
1 other identifier
interventional
200
1 country
1
Brief Summary
Efficient health care systems for the management of chronic diseases in the community may improve clinical outcomes and simultaneously encourage patients to remain healthy. Supportive care, may contribute to empower heart failure (HF) patients for self- management and providing them with the follow-up and care based on their needs and values through the HF trajectory. To develop the current program an assessment of the support needs of HF patients' will be undertaken and the investigators will take into consideration of their personal preferences, for instance means of communication and way of exercise as part of the intervention. The present study aspires to evaluate the effectiveness of an individualized supportive care management program in terms of the four different components that comprise supportive care in HF. The objectives of this study are to:
- 1.Determine supportive care needs of HF patients as reported in the literature.
- 2.Explore Cypriot patients' identified supportive care needs.
- 3.To develop and test a self-management supportive care programme for HF patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable heart-failure
Started Jan 2019
Typical duration for not_applicable heart-failure
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 15, 2019
CompletedFirst Submitted
Initial submission to the registry
March 4, 2020
CompletedFirst Posted
Study publicly available on registry
June 4, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 15, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 15, 2022
CompletedJune 4, 2020
May 1, 2020
2 years
March 4, 2020
May 31, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (25)
Minnessota Living with Heart Failure Questionnaire (Greek Version) MLHFQ (Gr version)
Quantitative data. MLHFQ consists of 21 items using a six-point Likert scale (scored 0-5), resulting in a total score in the range of 0-105, with higher scores reflecting poorer quality of life.
Baseline
Minnessota Living with Heart Failure Questionnaire (Greek Version) MLHFQ (Gr version)
quantitative data The items of the questionnaire examines 3 dimentions. The dimension scores were calculated as the sum of the items that represent each dimension. Higher scores indicate worse quality of life.
1st month
Minnessota Living with Heart Failure Questionnaire (Greek Version) MLHFQ (Gr version)
Quantitative data. MLHFQ consists of 21 items using a six-point Likert scale (scored 0-5), resulting in a total score in the range of 0-105, with higher scores reflecting poorer quality of life.
3rd month
Minnessota Living with Heart Failure Questionnaire (Greek Version) MLHFQ (Gr version)
Quantitative data. MLHFQ consists of 21 items using a six-point Likert scale (scored 0-5), resulting in a total score in the range of 0-105, with higher scores reflecting poorer quality of life.
6th month
Minnessota Living with Heart Failure Questionnaire (Greek Version) MLHFQ (Gr version)
Quantitative data. MLHFQ consists of 21 items using a six-point Likert scale (scored 0-5), resulting in a total score in the range of 0-105, with higher scores reflecting poorer quality of life.
one year
Audit of Diabetes Dependent Quality of Life - 19 Items ADDQoL-19 (Gr version)
quantitative data Individual domains of the questionnaire and Average Weighted Impact Score of the indivudual domains scores show maximum negative impact of diabetes (-9) and maximum positive impact of diabetes (+3)
Baseline
Audit of Diabetes Dependent Quality of Life - 19 Items ADDQoL-19 (Gr version)
quantitative data Individual domains of the questionnaire and Average Weighted Impact Score of the indivudual domains scores show maximum negative impact of diabetes (-9) and maximum positive impact of diabetes (+3)
1st month
Audit of Diabetes Dependent Quality of Life - 19 Items ADDQoL-19 (Gr version)
quantitative data Individual domains of the questionnaire and Average Weighted Impact Score of the indivudual domains scores show maximum negative impact of diabetes (-9) and maximum positive impact of diabetes (+3)
3rd month
Audit of Diabetes Dependent Quality of Life - 19 Items ADDQoL-19 (Gr version)
quantitative data Individual domains of the questionnaire and Average Weighted Impact Score of the indivudual domains scores show maximum negative impact of diabetes (-9) and maximum positive impact of diabetes (+3)
6th month
Audit of Diabetes Dependent Quality of Life - 19 Items ADDQoL-19 (Gr version)
quantitative data Individual domains of the questionnaire and Average Weighted Impact Score of the indivudual domains scores show maximum negative impact of diabetes (-9) and maximum positive impact of diabetes (+3)
one year
Multidimensional Scale of Perceived Social Support (Greek Version) MSPSS (Gr version)
Quantitative data MSPSS consists of 12 items using a six-point Likert scale (scored 1-7), resulting in a total score in the range of 12-84.The dimension scores were calculated as the summation of the items that repreresent each dimenson \[ 1. Family/Significant others , 2. Friends\] . Higher scores indicate higher perceived social support by Friends and Family/Signifciant Others.
Baseline
Multidimensional Scale of Perceived Social Support (Greek Version) MSPSS (Gr version)
Quantitative data MSPSS consists of 12 items using a six-point Likert scale (scored 1-7), resulting in a total score in the range of 12-84.The dimension scores were calculated as the summation of the items that repreresent each dimenson \[ 1. Family/Significant others , 2. Friends\] . Higher scores indicate higher perceived social support by Friends and Family/Signifciant Others.
1st month
Multidimensional Scale of Perceived Social Support (Greek Version) MSPSS (Gr version)
Quantitative data MSPSS consists of 12 items using a six-point Likert scale (scored 1-7), resulting in a total score in the range of 12-84.The dimension scores were calculated as the summation of the items that repreresent each dimenson \[ 1. Family/Significant others , 2. Friends\] . Higher scores indicate higher perceived social support by Friends and Family/Signifciant Others.
3rd month
Multidimensional Scale of Perceived Social Support (Greek Version) MSPSS (Gr version)
Quantitative data MSPSS consists of 12 items using a six-point Likert scale (scored 1-7), resulting in a total score in the range of 12-84.The dimension scores were calculated as the summation of the items that repreresent each dimenson \[ 1. Family/Significant others , 2. Friends\] . Higher scores indicate higher perceived social support by Friends and Family/Signifciant Others.
6th month
Multidimensional Scale of Perceived Social Support (Greek Version) MSPSS (Gr version)
Quantitative data MSPSS consists of 12 items using a six-point Likert scale (scored 1-7), resulting in a total score in the range of 12-84.The dimension scores were calculated as the summation of the items that repreresent each dimenson \[ 1. Family/Significant others , 2. Friends\] . Higher scores indicate higher perceived social support by Friends and Family/Signifciant Others.
one year
Hospital and Anxiety- Depression Scale (Greek Version) HADS (Gr version)
Quantitative data The HADS is a self-report rating scale of 14 items on a 4-point Likert scale (range 0-3). It is designed to measure anxiety and depression (7 items for each subscale). The total score is the sum of the 14 items, and for each subscale the score is the sum of the respective seven items (ranging from 0-21). Higher scores indicate worse quality of life.
Baseline
Hospital and Anxiety- Depression Scale (Greek Version) HADS (Gr version)
Quantitative data The HADS is a self-report rating scale of 14 items on a 4-point Likert scale (range 0-3). It is designed to measure anxiety and depression (7 items for each subscale). The total score is the sum of the 14 items, and for each subscale the score is the sum of the respective seven items (ranging from 0-21). Higher scores indicate worse quality of life.
1st month
Hospital and Anxiety- Depression Scale (Greek Version) HADS (Gr version)
Quantitative data The HADS is a self-report rating scale of 14 items on a 4-point Likert scale (range 0-3). It is designed to measure anxiety and depression (7 items for each subscale). The total score is the sum of the 14 items, and for each subscale the score is the sum of the respective seven items (ranging from 0-21). Higher scores indicate worse quality of life.
3rd month
Hospital and Anxiety- Depression Scale (Greek Version) HADS (Gr version)
Quantitative data The HADS is a self-report rating scale of 14 items on a 4-point Likert scale (range 0-3). It is designed to measure anxiety and depression (7 items for each subscale). The total score is the sum of the 14 items, and for each subscale the score is the sum of the respective seven items (ranging from 0-21). Higher scores indicate worse quality of life.
6th month
Hospital and Anxiety- Depression Scale (Greek Version) HADS (Gr version)
Quantitative data The HADS is a self-report rating scale of 14 items on a 4-point Likert scale (range 0-3). It is designed to measure anxiety and depression (7 items for each subscale). The total score is the sum of the 14 items, and for each subscale the score is the sum of the respective seven items (ranging from 0-21). Higher scores indicate worse quality of life.
one year
International Physical Activity Questionnaire (Greek Version) IPAQ (Gr version)
quantitative data In the classification of perceived physical activity via the IPAQ there were three categories ˙ low activity level, moderate activity and high activity level
Baseline
International Physical Activity Questionnaire (Greek Version) IPAQ (Gr version)
quantitative data In the classification of perceived physical activity via the IPAQ there were three categories ˙ low activity level, moderate activity and high activity level
1st month
International Physical Activity Questionnaire (Greek Version) IPAQ (Gr version)
quantitative data In the classification of perceived physical activity via the IPAQ there were three categories ˙ low activity level, moderate activity and high activity level
3rd month
International Physical Activity Questionnaire (Greek Version) IPAQ (Gr version)
quantitative data In the classification of perceived physical activity via the IPAQ there were three categories ˙ low activity level, moderate activity and high activity level
6th month
International Physical Activity Questionnaire (Greek Version) IPAQ (Gr version)
quantitative data In the classification of perceived physical activity via the IPAQ there were three categories ˙ low activity level, moderate activity and high activity level
one year
Secondary Outcomes (15)
Self -Care of Heart Failure Index (Greek Version) SCHFI -Gr
Baseline
Self -Care of Heart Failure Index (Greek Version) Gr-SCHFI
1st month
Self -Care of Heart Failure Index (Greek Version) Gr-SCHFI
3rd month
Self -Care of Heart Failure Index (Greek Version) Gr-SCHFI
6th month
Self -Care of Heart Failure Index (Greek Version) Gr-SCHFI
one year
- +10 more secondary outcomes
Study Arms (2)
intervention group
EXPERIMENTALsupportive care management programme
control group
NO INTERVENTIONreceive the usual care provided by the health care system of Cyprus
Interventions
Eligibility Criteria
You may qualify if:
- clinical diagnoses with HF (HFpEF or HFrEF), established by a cardiologist
- New York Heart Association classification stages I-IV
- Diagnosis established for at least 6 months before the start of the intervention period
- Ability to understand, write and read in Greek language
You may not qualify if:
- Refuse to take part in the research
- Dementia or other severe mental illness
- Transfer to nursing homes after discharge
- Difficulty in contacting them by a phone call
- Patients with chronic degenerative diseases (Alzheimer, cancer, etc)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cyprus University of Technology; Nursing Department
Limassol, 3036, Cyprus
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Ekaterini Lambrinou, PhD,MSc,BSc
Cyprus University of Technology
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- single-blinded
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
March 4, 2020
First Posted
June 4, 2020
Study Start
January 15, 2019
Primary Completion
January 15, 2021
Study Completion
January 15, 2022
Last Updated
June 4, 2020
Record last verified: 2020-05
Data Sharing
- IPD Sharing
- Will not share
only the 2 investigators of the study will share data